These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31558125)

  • 21. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
    Torre D; Casari S; Speranza F; Donisi A; Gregis G; Poggio A; Ranieri S; Orani A; Angarano G; Chiodo F; Fiori G; Carosi G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1346-9. PubMed ID: 9624473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients.
    Pakianathan MR; Kamarulzaman A; Ismail R; McMillan A; Scott GR
    AIDS; 1999 Sep; 13(13):1787-8. PubMed ID: 10509585
    [No Abstract]   [Full Text] [Related]  

  • 24. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute delirium induced by intravenous trimethoprim-sulfamethoxazole therapy in a patient with the acquired immunodeficiency syndrome.
    Salkind AR
    Hum Exp Toxicol; 2000 Feb; 19(2):149-51. PubMed ID: 10773846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 28. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS.
    Van Gerpen JA
    Neurology; 1997 Feb; 48(2):537-8. PubMed ID: 9040756
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
    Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The impact of the prevention of cerebral toxoplasmosis].
    Katlama C
    J Neuroradiol; 1995 Sep; 22(3):193-5. PubMed ID: 7472536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis.
    Marra CM; Krone MR; Koutsky LA; Holmes KK
    Int J STD AIDS; 1998 Dec; 9(12):761-4. PubMed ID: 9874125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperkalemia and trimethoprim-sulfamethoxazole.
    Ougorets I; Asnis DS; Melchert A
    Ann Intern Med; 1996 Nov; 125(9):779; author reply 779-80. PubMed ID: 8929021
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolated cerebellar toxoplasmosis as a complication of HIV infection.
    Pott H; Castelo A
    Int J STD AIDS; 2013 Jan; 24(1):70-2. PubMed ID: 23512507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
    Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A; Murri R; Ammassari A
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract]   [Full Text] [Related]  

  • 38. Glutathione in hypersensitivity to trimethoprim/sulfamethoxazole in patients with HIV infection.
    Rose EW; McCloskey WW
    Ann Pharmacother; 1998 Mar; 32(3):381-3. PubMed ID: 9533069
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cotrimoxazole for toxoplasmosis encephalitis: a cheaper and safer treatment?].
    Béraud G; Pierre-François S; Foltzer A; Smadja D; Cabié A
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S94-6. PubMed ID: 18598884
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
    Klinker H; Langmann P; Zilly M; Richter E
    J Clin Pharm Ther; 1998 Apr; 23(2):149-54. PubMed ID: 9786102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.